|
Sensitive, nonradioactive cyclic-AMP detection kit and adenylate cyclase
(AC) toxin
Enzyme Immunoassay for Studying Intracellular Levels of cAMP
Danny Q. Hoang
Stratagene Cloning Systems, Inc.
Xinping Yang and Timothy G. Kingan, Ph.D.
American Qualex
Stratagene’s EIA cAMP Kit is a highly sensitive and specific
antibody-based assay kit for nonradioactive, quantitative measurement of
intracellular levels of cAMP. The assay is based on the competition between cAMP
present in the sample and a fixed quantity of a cAMP-horseradish peroxidase
conjugate for a limited number of binding sites on cAMP-specific antibodies.
When the amounts of antibody and peroxidase-labeled cAMP are fixed, the amount
of peroxidase-labeled cAMP that binds to the antibody is inversely proportional
to the concentration of added, unlabeled cAMP in the sample. In this enzyme
immunoassay (EIA) format, each microtiter plate is precoated with a secondary
antibody, goat anti-rabbit IgG, which binds to a fixed amount of rabbit
anti-cAMP. The amount of peroxidase-labeled cAMP bound to the antibody is
determined by the addition of a colorimetric substrate, and the resulting color
is measured by reading the spectrophotometric absorbance at 450 nm. The
sensitivity of the EIA cAMP Kit is in the nanomolar range, and sensitivity is
increased to the picomolar range with acetylated cAMP.
Cyclic adenosine monophosphate (cAMP) plays a key role as an intracellular
second messenger for transduction events that follow a number of extracellular
signals. Typically, the binding of a hormone or neuromodulator to its receptor
is followed by the activation of a G protein, which, in turn, activates the
effector adenylyl cyclase evoking the production of cAMP. The activation
of a protein kinase by cAMP results in the phosphorylation of substrate
proteins, which include enzymes, ion channels and transcription regulators.
Because cAMP can activate a cascade of reactions, the involvement of cAMP
greatly amplifies the response to a hormonal stimulus.
Nonradioactive Detection of cAMP

figure
1
Since changes in cAMP levels can result in the activation of proteins
known to play key roles in signal transduction cascades, quantitative
measurment of cAMP can serve to identify signaling events. Popular methods
for determining cAMP levels include radioimmunoassays (RIA). Although
these assays are highly sensitive, they require radioisotopes and time-consuming
protocols. In contrast, Stratagene’s nonradioactive EIA cAMP Kit
uses a competitive EIA (figure
1) assay for simple and sensitive measurement of intracellualar cAMP
levels. The assay is based on the competition between cAMP present in
the sample and a fixed quantity of a cAMP-peroxidase conjugate that binds
to rabbit anti-cAMP-specific antibodies.

figure 2
The assay is performed in a microtiter plate, with each well precoated
with goat anti-rabbit IgG. Rabbit anti-cAMP antibodies are combined with
the sample and cAMP-horseradish peroxidase conjugate (tracer) and applied
to the microtiter well. Samples containing cAMP compete with a fixed quantity
of tracer for the rabbit anti-cAMP-specific antibodies. All unbound reagents
are removed by a wash step. The reaction is completed by the addition
of the colorimetric substrate, 3,3¢,5,5¢-tetramethylbenzidine/hydrogen
peroxide (TMB/H2O2). The addition of TMB/H2O2
to each well results in a blue-green product background, and the reaction
is stopped by the addition of 1 M phosphoric acid. A bright yellow color
results, and absorbance of peroxidase-labeled cAMP that is bound to the
cAMP-specific antibody is determined using a spectrophoto- metric
plate reader at 450 nm. Since the amount of cAMP-horseradish peroxidase
bound to rabbit anti-cAMP antibody is inversely proportional to cAMP in
the sample (or standard), a high absorbance value corresponds to low levels
of cAMP present in the sample. The EIA cAMP Kit includes cAMP standards
for calculating standard curves. As an option for increased sensitivity
(figure
2), standards and prepared samples can be acetylated by treatment
with acetic anhydride in the presence of triethylamine.1 Picomolar
detection is possible for acetylated cAMP, whereas nonacetylated cAMP
levels can generally be assayed in the nanomolar range. The EIA cAMP Kit
includes all the re- agents and protocols for quantifying cAMP levels
in both nonacetylated and acetylated preparations.
AC Toxin for Increased Intracellular cAMP Levels
Stratagene is offering adenylate cyclase (AC) toxin, a useful reagent for
increasing intracellular cAMP levels in cultured cells. AC toxin can be used to
study cAMP-dependent protein kinase activation, the key regulatory event in
signal transduction pathways involving cAMP. Modulators currently available for
examining the effects of cAMP on intracellular signaling include dibutyryl cAMP2
or 8-bromo-cAMP, cholera toxin (CT),2 3-isobutyl-1-methylxanthine
(IBMX)3 and forskolin.4 AC toxin has been shown to elevate
intracellular cAMP in cultured cells5 and can be used as an
alternative to agonists that increase cAMP levels. AC toxin has an apparent
molecular weight of 200 to 216 kDa by SDS-PAGE.6 Stratagene’s AC
toxin has been purified from E. Coli 7 and is supplied
as lyophilized powder sealed under vacuum. When reconstituted in 50 µl
distilled water, each vial contains 50 µg of AC toxin in 20 mM HEPES, pH 7.5
and 8 M urea.
AC toxin activity was determined by quantitation of intracellular cAMP
accumulation in Jurkat8 cells using Stratagene’s EIA cAMP Kit.
Jurkat cells were maintained in RPMI 1640 medium supplemented with 10%
heat-inactivated fetal bovine serum, 2 mM glutamine, 1 mM sodium pyruvate, 0.1
mM nonessential amino acids, 50 units/ml penicillin and 50 mg/ml streptomycin in
a humidified, 370C, 5% CO2 incubator. Various
concentrations of AC toxin were added to the cells (1 x 106/ml), and
intracellular cAMP levels were quantified.

figure
3
AC toxin elevates intracellular cAMP levels in Jurkat cells (figure
3). cAMP levels were elevated by as little as 0.5 µg/ml of AC toxin,
although 2.0 µg/ml seems to be the optimal concentration for elevating
values of cAMP. A 5-fold increase in the AC toxin concentration to 10
µg/ml resulted in decreased intracellular cAMP levels, suggesting that
cAMP production levels off at high concentrations of AC toxin.9
Stratagene recommends that researchers vary levels of AC toxin within
this range (0.5 to 10 µg/ml) to ensure maximal stimulation in the cell
line of interest. In addition to Jurkat cells, AC toxin has also been
shown to elevate cAMP in monocyte macrophages,10 polymorphonuclear
leukocytes and alveolar macrophages,11 natural killer cells12
and HL-60 promyelocytic leukemia cells.13
Conclusions
The EIA cAMP Kit is a nonradioactive EIA system for measuring intracellular cAMP levels. The kit is simple, convenient and highly sensitive and allows determination of cAMP levels from cell culture or tissue preparations. Intracellular cAMP levels can be detected in the nanomolar or picomolar range. Stratagene also offers AC toxin, which significantly increases intracellular cAMP levels as an alternative to currently available cAMP agonists.
REFERENCES
-
Brooker, G., et al. (1979) Adv. Cyclic Nucleotide Res.
10: 10.
-
Barnes, S.J., and Conn, P.M. (1993) Endocrinology
133: 2756-2760.
-
Wells, J.N., et al. (1975) Mol. Pharmacol. 11: 775.
-
Seamon, K.B., and Daly, J.W. (1986) Adv. Cyclic
Nucleotide Protein Phosphorylation Res. 20: 1.
-
Selfe, S., et al. (1987) Mol. Pharmacol. 31:
529-534.
-
Hewlett, E.L., et al. (1982) J. Biol. Chem. 268:
7842-7848.
-
Sebo, P., et al. (1991) Gene 104: 19-24.
-
Confer, D.L., and Eaton, J.W. (1982) Science 217:
948-950.
-
Gentile, F., et al. (1988) Eur. J. Biochem. 175:
447-453.
-
Hewlett, E.L., et al. (1983) Clin. Res. 31: 365A.
-
Hewlett, E.L., et al. (1989) J. Biol. Chem. 264:
19379-19389.
-
Hewlett, E.L., et al. (1993) J. Biol. Chem. 268:
7842-7848.
-
Slungaard, A., et al. (1983) Clin. Res. 31: 547A.
|
|